Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1964 1
1970 1
1972 1
1979 3
1980 3
1983 1
1986 2
1993 1
1994 2
2000 1
2004 2
2005 1
2012 1
2013 1
2015 1
2016 1
2019 1
2020 1
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Incidental image memorability.
Goetschalckx L, Moors J, Wagemans J. Goetschalckx L, et al. Among authors: moors j. Memory. 2019 Oct;27(9):1273-1282. doi: 10.1080/09658211.2019.1652328. Epub 2019 Aug 11. Memory. 2019. PMID: 31402784
A Polynesian-specific missense CETP variant alters the lipid profile.
Moors J, Krishnan M, Sumpter N, Takei R, Bixley M, Cadzow M, Major TJ, Phipps-Green A, Topless R, Merriman M, Rutledge M, Morgan B, Carlson JC, Zhang JZ, Russell EM, Sun G, Cheng H, Weeks DE, Naseri T, Reupena MS, Viali S, Tuitele J, Hawley NL, Deka R, McGarvey ST, de Zoysa J, Murphy R, Dalbeth N, Stamp L, Taumoepeau M, King F, Wilcox P, Rapana N, McCormick S, Minster RL, Merriman TR, Leask M. Moors J, et al. HGG Adv. 2023 May 8;4(3):100204. doi: 10.1016/j.xhgg.2023.100204. eCollection 2023 Jul 13. HGG Adv. 2023. PMID: 37250494 Free PMC article.
A stop-gain variant in BTNL9 is associated with atherogenic lipid profiles.
Carlson JC, Krishnan M, Rosenthal SL, Russell EM, Zhang JZ, Hawley NL, Moors J, Cheng H, Dalbeth N, de Zoysa JR, Watson H, Qasim M, Murphy R, Naseri T, Reupena MS, Viali S, Stamp LK, Tuitele J, Kershaw EE, Deka R, McGarvey ST, Merriman TR, Weeks DE, Minster RL. Carlson JC, et al. Among authors: moors j. HGG Adv. 2022 Oct 12;4(1):100155. doi: 10.1016/j.xhgg.2022.100155. eCollection 2023 Jan 12. HGG Adv. 2022. PMID: 36340932 Free PMC article.
A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions.
Ewart L, Milne A, Adkins D, Benjamin A, Bialecki R, Chen Y, Ericsson AC, Gardner S, Grant C, Lengel D, Lindgren S, Lowing S, Marks L, Moors J, Oldman K, Pietras M, Prior H, Punton J, Redfern WS, Salmond R, Skinner M, Some M, Stanton A, Swedberg M, Finch J, Valentin JP. Ewart L, et al. Among authors: moors j. J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):30-43. doi: 10.1016/j.vascn.2013.04.008. Epub 2013 May 9. J Pharmacol Toxicol Methods. 2013. PMID: 23665080
29 results